UK markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.45-0.22 (-1.18%)
As of 01:20PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts17171715
Avg. Estimate-0.66-0.66-2.67-2.61
Low estimate-0.85-0.85-3.31-3.32
High estimate-0.44-0.39-1.54-1.31
Year ago EPS1.3-0.72-1.06-2.67
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts13121715
Avg. Estimate15.23M13.39M47.48M111.48M
Low estimateN/AN/AN/AN/A
High estimate33.38M36.9M124M367.25M
Year ago sales13.46M1.27M330.53M47.48M
Sales growth (year/est)13.20%956.80%-85.60%134.80%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.68-0.8-0.8-0.7
Actual EPS1.3-0.72-0.86-0.68
Difference1.980.08-0.060.02
Surprise %291.20%10.00%-7.50%2.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.66-0.66-2.67-2.61
7 days ago-0.66-0.66-2.6-2.59
30 days ago-0.67-0.67-2.64-2.59
60 days ago-0.69-0.67-2.69-2.67
90 days ago-0.55-0.76-2.96-2.48
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days3467
Up last 30 days5688
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5345
Growth estimatesDNLIIndustrySector(s)S&P 500
Current qtr.-150.80%N/AN/AN/A
Next qtr.8.30%N/AN/AN/A
Current year-151.90%N/AN/AN/A
Next year2.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A